Lexington, KY, United States of America

Eric Michael Ostertag

USPTO Granted Patents = 32 

 

 

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 98(Granted Patents)


Location History:

  • Lexington, KY (US) (2012 - 2023)
  • San Diego, CA (US) (2019 - 2023)
  • Del Mar, CA (US) (2021 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
32 patents (USPTO):Explore Patents

Title: Exploring the Innovator: Eric Michael Ostertag

Introduction

Eric Michael Ostertag, based in Lexington, KY, is a renowned innovator with an impressive portfolio of 28 patents. His contributions to the field of biotechnology, particularly in developing advanced animal models for research and therapeutic applications, have marked significant advancements in the area of genetic engineering.

Latest Patents

Among Ostertag's latest patents is a groundbreaking invention titled "Genetically Modified Rat Models for Severe Combined Immunodeficiency (SCID)." This invention focuses on engineering mammalian cells, specifically rats, which exhibit deficiencies due to disruptions in tumor suppressor genes or gene products. The genetically modified rats, along with their descendants and ancestors, serve as vital animal models for studying human cancer and developing related methods.

Another notable patent is for "Superpiggybac Transposase Compositions." This disclosure outlines a method for producing modified stem memory T cells, such as CAR-T cells. These modified T cells are intended for therapeutic administration, including applications in adoptive cell therapies aimed at treating various cancers and diseases.

Career Highlights

Eric Michael Ostertag has built a notable career in the biotechnology industry, contributing significantly to both research and development. He has held key positions at leading companies in the field, such as Poseida Therapeutics, Inc. and Transposagen Biopharmaceuticals, Inc. His work has influenced advancements in genetic research and therapeutic innovations.

Collaborations

Throughout his career, Ostertag has collaborated with several notable individuals, including Devon Shedlock and John Stuart Crawford. These partnerships have fostered a collaborative environment for research and innovation, promoting the development of new technologies and methods within the biotechnology sector.

Conclusion

Eric Michael Ostertag's work exemplifies the spirit of innovation in biotechnology. With his extensive patent portfolio and successful collaborations, he continues to push the boundaries of science. His contributions are not only advancing our understanding of genetic engineering but also paving the way for novel therapeutic applications that can greatly benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…